Cargando…

Brief Report of Anti–Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC Therapy

In the recent past, we observed an increased risk of cancer in the population with human immunodeficiency virus (HIV) owing to the development of antiretroviral therapies that decreased mortality caused by HIV-specific infections. This particularly fragile population is frequently excluded from clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bertin, Lise, Canellas, Anthony, Abbar, Baptiste, Veyri, Marianne, Spano, Jean-Philippe, Cadranel, Jacques, Lavolé, Armelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605183/ https://www.ncbi.nlm.nih.gov/pubmed/34825236 http://dx.doi.org/10.1016/j.jtocrr.2021.100247

Ejemplares similares

Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer
por: Baron, Marine, et al.
Publicado: (2022)

Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer
por: Cadranel, Jacques, et al.
Publicado: (2019)

Local ablative therapy in oncogenic-driven oligometastatic non-small cell lung cancer: present and ongoing strategies—a narrative review
por: Fallet, Vincent, et al.
Publicado: (2021)

Anti-PD-1 immune-related adverse events are associated with high therapeutic antibody fixation on T cells
por: Gazzano, Marianne, et al.
Publicado: (2022)

Factors associated with early progression of non-small-cell lung cancer treated by epidermal growth factor receptor tyrosine-kinase inhibitors
por: Rozensztajn, Nathalie, et al.
Publicado: (2014)

Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number Alterations
por: Bouzidi, Amira, et al.
Publicado: (2021)

Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use?
por: Gougis, Paul, et al.
Publicado: (2020)

Reversible Tumor Progression Induced by a Dexamethasone Course for Severe COVID-19 during Immune Checkpoint Inhibitor Treatment
por: Gougis, Paul, et al.
Publicado: (2022)

Feline immunodeficiency virus: A brief review
por: Bennett, M., et al.
Publicado: (1992)

Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin–gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study
por: Borget, Isabelle, et al.
Publicado: (2014)

Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial
por: Dubois, Fatéméh, et al.
Publicado: (2019)

Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO)
por: Wislez, Marie, et al.
Publicado: (2022)

Augmentation des délais de prise charge du cancer du poumon pendant la pandémie COVID-19 : expérience d’un centre de diagnostic rapide ambulatoire
por: Wang, P., et al.
Publicado: (2022)

Seeking Relevant Biomarkers in Common Variable Immunodeficiency
por: Ho, Hsi-en, et al.
Publicado: (2022)

Symmetry‐Breaking Charge‐Transfer Chromophore Interactions Supported by Carbon Nanodots
por: Cacioppo, Michele, et al.
Publicado: (2020)

Brief report: risk stratification following curative therapy for stage I NSCLC
por: Butts, Emily, et al.
Publicado: (2023)

Case Report: Zellweger Syndrome and Humoral Immunodeficiency: The Relevance of Newborn Screening for Primary Immunodeficiency
por: Fazi, C., et al.
Publicado: (2022)

Relevance of Teledentistry: Brief Report and Future Perspectives
por: Fornaini, Carlo, et al.
Publicado: (2022)

Patients’ Attitude toward Breaking Bad News; a Brief Report
por: Aminiahidashti, Hamed, et al.
Publicado: (2016)

MLTI-03. The relevance of the count of brain metastases for treatment and outcome in NSCLC
por: Reinecke, David, et al.
Publicado: (2021)

Brief Report: Contralateral Lobectomy for Second Primary NSCLC: Perioperative and Long-Term Outcomes
por: Choe, Jennie K., et al.
Publicado: (2022)

Immune Reconstitution Inflammatory Syndrome Associated Kaposi Sarcoma
por: Poizot-Martin, Isabelle, et al.
Publicado: (2022)

Update on DNA-Double Strand Break Repair Defects in Combined Primary Immunodeficiency
por: Slatter, Mary A., et al.
Publicado: (2020)

Breaking the crosstalk of the cellular tumorigenic network: Hypothesis for addressing resistances to targeted therapies in advanced NSCLC
por: Langhammer, Stefan, et al.
Publicado: (2017)

Grade 3–4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study
por: Guezour, Nadia, et al.
Publicado: (2022)

Breaking (Fake) News: No Personal Relevance Effect on Misinformation Vulnerability
por: Ceccarini, Francesco, et al.
Publicado: (2023)

Relevance of laboratory testing for the diagnosis of primary immunodeficiencies: a review of case-based examples of selected immunodeficiencies
por: Abraham, Roshini S
Publicado: (2011)

Current challenges of unresectable stage III NSCLC: are we ready to break the glass ceiling of the PACIFIC trial?
por: Remon, Jordi, et al.
Publicado: (2022)

Macrophages and their relevance in Human Immunodeficiency Virus Type I infection
por: Koppensteiner, Herwig, et al.
Publicado: (2012)

Brief Report: A Blood-Based MicroRNA Complementary Diagnostic Predicts Immunotherapy Efficacy in Advanced-Stage NSCLC With High Programmed Death-Ligand 1 Expression
por: Rajakumar, Timothy, et al.
Publicado: (2022)

Kaposi’s Sarcoma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi’s Sarcoma
por: Jary, Aude, et al.
Publicado: (2021)

Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients
por: Palich, R., et al.
Publicado: (2021)

Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives
por: Leprieur, Etienne Giroux, et al.
Publicado: (2016)

Death in the hospital: Breaking the bad news to the bereaved family
por: Naik, Sadananda B.
Publicado: (2013)

Macaque-tropic human immunodeficiency virus type 1: breaking out of the host restriction factors
por: Saito, Akatsuki, et al.
Publicado: (2013)

Recent death early warning value of ECG changes in patients with NSCLC
por: Liu, Qiong, et al.
Publicado: (2023)

New modalities of cancer treatment for NSCLC: focus on immunotherapy
por: Davies, Marianne
Publicado: (2014)

High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer
por: van den Broek, Evert, et al.
Publicado: (2015)

Clustered DNA Double-Strand Breaks: Biological Effects and Relevance to Cancer Radiotherapy
por: Nickoloff, Jac A., et al.
Publicado: (2020)

Kaposi’s Sarcoma in Virally Suppressed People Living with HIV: An Emerging Condition
por: Palich, Romain, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iglqogh5shmltdir51v0god7le